547 related articles for article (PubMed ID: 16307386)
1. Nanoparticles of poorly water-soluble drugs prepared by supercritical fluid extraction of emulsions.
Shekunov BY; Chattopadhyay P; Seitzinger J; Huff R
Pharm Res; 2006 Jan; 23(1):196-204. PubMed ID: 16307386
[TBL] [Abstract][Full Text] [Related]
2. Drug encapsulation using supercritical fluid extraction of emulsions.
Chattopadhyay P; Huff R; Shekunov BY
J Pharm Sci; 2006 Mar; 95(3):667-79. PubMed ID: 16447174
[TBL] [Abstract][Full Text] [Related]
3. Griseofulvin micronization and dissolution rate improvement by supercritical assisted atomization.
Reverchon E; Della Porta G; Spada A; Antonacci A
J Pharm Pharmacol; 2004 Nov; 56(11):1379-87. PubMed ID: 15525444
[TBL] [Abstract][Full Text] [Related]
4. Fast drying of biocompatible polymer films loaded with poorly water-soluble drug nano-particles via low temperature forced convection.
Susarla R; Sievens-Figueroa L; Bhakay A; Shen Y; Jerez-Rozo JI; Engen W; Khusid B; Bilgili E; Romañach RJ; Morris KR; Michniak-Kohn B; Davé RN
Int J Pharm; 2013 Oct; 455(1-2):93-103. PubMed ID: 23911341
[TBL] [Abstract][Full Text] [Related]
5. Micronized powders of a poorly water soluble drug produced by a spray-freezing into liquid-emulsion process.
Rogers TL; Overhoff KA; Shah P; Santiago P; Yacaman MJ; Johnston KP; Williams RO
Eur J Pharm Biopharm; 2003 Mar; 55(2):161-72. PubMed ID: 12637092
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticles in the pharmaceutical industry and the use of supercritical fluid technologies for nanoparticle production.
Sheth P; Sandhu H; Singhal D; Malick W; Shah N; Kislalioglu MS
Curr Drug Deliv; 2012 May; 9(3):269-84. PubMed ID: 22283656
[TBL] [Abstract][Full Text] [Related]
7. Preparation of griseofulvin nanoparticles from water-dilutable microemulsions.
Trotta M; Gallarate M; Carlotti ME; Morel S
Int J Pharm; 2003 Mar; 254(2):235-42. PubMed ID: 12623199
[TBL] [Abstract][Full Text] [Related]
8. Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives.
Cho E; Cho W; Cha KH; Park J; Kim MS; Kim JS; Park HJ; Hwang SJ
Int J Pharm; 2010 Aug; 396(1-2):91-8. PubMed ID: 20558265
[TBL] [Abstract][Full Text] [Related]
9. Production of griseofulvin nanoparticles using supercritical CO(2) antisolvent with enhanced mass transfer.
Chattopadhyay P; Gupta RB
Int J Pharm; 2001 Oct; 228(1-2):19-31. PubMed ID: 11576765
[TBL] [Abstract][Full Text] [Related]
10. Investigation of preparation parameters to improve the dissolution of poorly water-soluble meloxicam.
Ambrus R; Kocbek P; Kristl J; Sibanc R; Rajkó R; Szabó-Révész P
Int J Pharm; 2009 Nov; 381(2):153-9. PubMed ID: 19616609
[TBL] [Abstract][Full Text] [Related]
11. An Intensified Vibratory Milling Process for Enhancing the Breakage Kinetics during the Preparation of Drug Nanosuspensions.
Li M; Zhang L; Davé RN; Bilgili E
AAPS PharmSciTech; 2016 Apr; 17(2):389-99. PubMed ID: 26182907
[TBL] [Abstract][Full Text] [Related]
12. Comminution of ibuprofen to produce nano-particles for rapid dissolution.
Plakkot S; de Matas M; York P; Saunders M; Sulaiman B
Int J Pharm; 2011 Aug; 415(1-2):307-14. PubMed ID: 21683776
[TBL] [Abstract][Full Text] [Related]
13. Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system.
Chattopadhyay P; Shekunov BY; Yim D; Cipolla D; Boyd B; Farr S
Adv Drug Deliv Rev; 2007 Jul; 59(6):444-53. PubMed ID: 17582648
[TBL] [Abstract][Full Text] [Related]
14. Redispersible fast dissolving nanocomposite microparticles of poorly water-soluble drugs.
Bhakay A; Azad M; Bilgili E; Dave R
Int J Pharm; 2014 Jan; 461(1-2):367-79. PubMed ID: 24333905
[TBL] [Abstract][Full Text] [Related]
15. Preparation of polycaprolactone nanoparticles via supercritical carbon dioxide extraction of emulsions.
Ajiboye AL; Trivedi V; Mitchell JC
Drug Deliv Transl Res; 2018 Dec; 8(6):1790-1796. PubMed ID: 28828703
[TBL] [Abstract][Full Text] [Related]
16. Enhanced recovery and dissolution of griseofulvin nanoparticles from surfactant-free nanocomposite microparticles incorporating wet-milled swellable dispersants.
Bhakay A; Azad M; Vizzotti E; Dave RN; Bilgili E
Drug Dev Ind Pharm; 2014 Nov; 40(11):1509-22. PubMed ID: 23981202
[TBL] [Abstract][Full Text] [Related]
17. Physical properties of griseofulvin-lipid nanoparticles in suspension and their novel interaction mechanism with saccharide during freeze-drying.
Kamiya S; Kurita T; Miyagishima A; Itai S; Arakawa M
Eur J Pharm Biopharm; 2010 Mar; 74(3):461-6. PubMed ID: 20018239
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS Class II drug nanoparticles for pharmaceutical applications.
Sievens-Figueroa L; Bhakay A; Jerez-Rozo JI; Pandya N; Romañach RJ; Michniak-Kohn B; Iqbal Z; Bilgili E; Davé RN
Int J Pharm; 2012 Feb; 423(2):496-508. PubMed ID: 22178619
[TBL] [Abstract][Full Text] [Related]
19. Critical material attributes (CMAs) of strip films loaded with poorly water-soluble drug nanoparticles: III. Impact of drug nanoparticle loading.
Krull SM; Moreno J; Li M; Bilgili E; Davé RN
Int J Pharm; 2017 May; 523(1):33-41. PubMed ID: 28315716
[TBL] [Abstract][Full Text] [Related]
20. Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process.
Ha ES; Kim JS; Baek IH; Yoo JW; Jung Y; Moon HR; Kim MS
Drug Des Devel Ther; 2015; 9():4269-77. PubMed ID: 26345723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
